搜索筛选:
搜索耗时2.2834秒,为你在为你在102,285,761篇论文里面共找到 26 篇相符的论文内容
类      型:
[期刊论文] 作者:L UO Min-xia, 来源:数学季刊:英文版 年份:2010
在这份报纸,我们与伪理想关于丰富的 semigroup 讨论一些性质足够的 transversal.Moreover,我们证明满足一些的丰富的 semigroup 的足够的 transversals 调节的二伪理想的产品...
[期刊论文] 作者:LI Min-xia,LIU Bi-cheng, 来源:中华医学杂志(英文版) 年份:2004
Objective To review the mechanisms of epithelial to mesenchymal transition (EMT) and its role in the progression of tubulointerstitial fibrosis.Data sources The...
[期刊论文] 作者:Liu Min-Xia,Gan Zi-Zhao, 来源:中国物理(英文版) 年份:2007
The upper critical field of clean MgB2 is investigated using the two-band layered Ginzburg-Landau (GL) theory.The calculated results are fitted to the experimen...
[会议论文] 作者:ZHAO Wei-zhong,ZHU Min-xia,ZHOU Qi, 来源:2007世界神经创伤新进展大会(International Conference on Recent Advances 年份:2007
[会议论文] 作者:Feng Gao,Min-Xia Yao,Jing-Lin Zuo, 来源:第六届全国物理无机化学会议 年份:2012
[会议论文] 作者:Min-Xia Liu,Ke-Cheng Zhou,Yi Cao, 来源:2014第七届世界癌症大会 年份:2014
Lung cancer has become the leading cause of cancer-related deaths in the world.Lung cancer initiation and progression are predominately by genetic alteration of oncogenes and tumor suppressor genes.In...
[会议论文] 作者:Feng Gao,Min-Xia Yao,Yu-Yang Li,Jing-Lin Zuo, 来源:中国化学会第六届全国结构化学学术会议 年份:2012
[会议论文] 作者:Gui-yuan LV,Xia-li TANG,Jie SU,Min-xia PANG,Su-hong CHEN, 来源:The 12th Meeting of the Asia Pacific Federation of Pharmacol 年份:2013
[会议论文] 作者:Zheng-Hai Tang,Min-Xia Su,Wen-Xiang Cao,Xiuping Chen,Jin-Jian Lu, 来源:第五届广州国际肿瘤学会议暨第一届中国抗癌协会肿瘤靶向治疗专业委员会年会 年份:2016
Osimertinib(OSI),also known as AZD9291,is a third-generation epidermal growth factor receptor tyrosine kinase inhibitor that has been approved for the treatment of non-small cell lung cancer(NSCLC)pat...
[会议论文] 作者:Fang Wang,Xue Wang,Min-Xia Zhang,Yong-Hna Yang,Hai-Liang Zhu, 来源:第八届国际分子模拟与信息技术应用学术会议 年份:2016
A series of novel compounds(8a-21b)were designed and synthesized based on lH-benzo[d]imidazole.Their biological activities were evaluated as potential tubulin polymerization inhibitors and anticancer...
[会议论文] 作者:Gui-yuan LV,Su-hong CHEN,Xia-li TANG,Jie SU,Min-xia PANG, 来源:The 12th Meeting of the Asia Pacific Federation of Pharmacol 年份:2013
Aim: Referring to the relation between hypertension and long-term high-purine diet, we established the hypertension model mice by feeding with high-purine food, which is similar to human diseases.Meth...
[期刊论文] 作者:Long CHEN,Bi-cheng LIU,Xiao-liang ZHANG,Jian-dong ZHANG,Hong LIU,Min-xia LI, 来源:中国药理学报(英文版) 年份:2006
Aim: The present study was designed to further investigate the effect of connective tissue growth factor antisense oligonucleotide (CTGF-AS) on angiotensin Ⅱ (...
[期刊论文] 作者:HUANG Ru-Tong,LI Xiao-Yu,XIA Xiao-Bing,YUAN Xi-Tong,LIU Min-Xia,LI De-Rong, 来源:城市道桥与防洪 年份:1999
该文从挂篮荷载计算、施工流程、支座及临时固结施工、挂篮安装及试验、合拢段施工、模板制作安装、钢筋安装、混凝土的浇筑及养生、测量监控等方面人手,介绍了S226海滨大桥...
[期刊论文] 作者:CAI Xu-Min,CHEN Xin-Fei,MU Tian-Qi,LIN Yu-Ting,HUANG Shen-Lin,YAO Min-Xia, 来源:结构化学 年份:2020
Two Schiff bases (DAMBA-Fc and DAA-Fc) derived from dehydroabietic acid have been successfully synthesized and characterized by means of FT-IR,elemental analysi...
[期刊论文] 作者:Su-hong CHEN,Min-xia PANG,Ying-ying MA,Hui-ming HU,Rui-li YU,Gui-yuan LYU,, 来源:中国药理学与毒理学杂志 年份:2015
OBJECTIVE In recent years,the frequency of hyperuricemia has gradually risen along with the improvement of living standards,the irregular of diet and overfeedin...
[期刊论文] 作者:Min-xia PANG,Ying-ying MA,Hui-ming HU,Jie SU,Su-hong CHEN,Gui-yuan LYU,, 来源:中国药理学与毒理学杂志 年份:2015
OBJECTIVE Di.E and Gpm.E were separately extracted from two kinds of traditional Chinese medicine.The aim of this research is to investigate the combined anti-h...
[会议论文] 作者:Zheng-Hai Tang,Min-Xia Su,Xia Guo,Xiao-Ming Jiang,Xiuping Chen,Jin-Jian Lu, 来源:2016医学科学前沿暨第四届个体化治疗与抗肿瘤药物研究新趋向研讨会 年份:2016
Objective: The third generation epidermal growth factor receptor(EGFR)tyrosine kinase inhibitor(TKI)osimertinib(OSI,also known as AZD9291)has been approved for treatment of EGFR T790M positive mutatio...
[会议论文] 作者:Zheng-Hai Tang,Min-Xia Su,Xia Guo,Xiao-Ming Jiang,Xiuping Chen,Jin-Jian Lu, 来源:第五届广州国际肿瘤学会议暨第一届中国抗癌协会肿瘤靶向治疗专业委员会年会 年份:2016
Objective: The third generation epidermal growth factor receptor(EGFR)tyrosine kinase inhibitor(TKI)osimertinib(OSI,also known as AZD9291)has been approved for treatment of EGFR T790M positive mutatio...
[期刊论文] 作者:Xiao-Ming JIANG,Yu-Lian XU,Mu-Yang HUANG,Le-Le ZHANG,Min-Xia SU,Xiuping CHEN,Jin-Jian LU, 来源:中国药理学报(英文版) 年份:2017
Osimertinib (AZD9291) is a third-generation epidermal growth factor receptor (EGFR) tyrosine kinase inhibitor (TKI) that has been approved for the treatment of...
[会议论文] 作者:Jun-Bo Peng,Min-Xia Liang,Yan-Ping Ren,Xiang-Jian Kong,La-Sheng Long,Rong-Bin Huang,Lan-Sun Zheng, 来源:第11届固体化学与无机合成会议暨第二届道尔顿交易国际研讨会 年份:2010
相关搜索: